John Newman
Stock Analyst at Canaccord Genuity
(1.02)
# 2126
Out of 5,370 analysts
120
Total ratings
46.67%
Success rate
-1.56%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Buy | 1152 850 | 522.29 | 62.74% | 15 | Apr 22, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Buy | 14 14 | 1.36 | 929.41% | 3 | Mar 14, 2025 | |
BNTX BioNTech | Maintains: Buy | 172 172 | 106.15 | 61.51% | 8 | Mar 11, 2025 | |
ATRA Atara Biotherapeutic... | Maintains: Buy | 17 17 | 8.55 | 98.83% | 5 | Mar 11, 2025 | |
MRKR Marker Therapeutics | Initiates Coverage On: Buy | 8 | 1.5 | 433.33% | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 20 25 | 5.16 | 384.5% | 2 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 200 200 | 7.46 | 2580.97% | 9 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 10 | n/a | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 21 | 15.39 | 36.45% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 115 | 64.14 | 79.3% | 8 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 8 | 0.71 | 1026.76% | 6 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 67 | 53.25 | 25.82% | 2 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 38 43 | 10.33 | 316.26% | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 450 180 | n/a | n/a | 1 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 11 | n/a | n/a | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 25 | n/a | n/a | 5 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | 0.64 | 681.25% | 2 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 9 | n/a | n/a | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 40 72 | n/a | n/a | 4 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 44 | 35.5 | 23.94% | 8 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1720 400 | n/a | n/a | 3 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 100 140 | n/a | n/a | 1 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 65 56 | n/a | n/a | 7 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 380 100 | n/a | n/a | 2 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Oct 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 210 220 | 9.06 | 2328.26% | 3 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 54 0 | n/a | n/a | 3 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 300 | n/a | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 38 | 16.79 | 126.33% | 2 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 30 | n/a | n/a | 2 | Sep 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 27 | 3.02 | 794.04% | 2 | Sep 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Speculative Buy | n/a | n/a | n/a | 1 | Sep 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 18 | n/a | n/a | 1 | Aug 30, 2016 |